FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula I or a pharmaceutically acceptable salt thereof, which can be used to treat a disorder, a disease or a condition mediated by a BRD4 target protein. In formula I, X1 is a divalent fragment selected from -C(O)-; R1 is hydrogen; each R2 is independently hydrogen or -R6; ring A is , where ring B is a fused ring selected from 6-member aryl containing 0–2 nitrogen atoms; each R4 is independently hydrogen or -R6; each R6 is C1-6 alkyl; L is a divalent saturated linear C1-20 hydrocarbon chain, where 0–6 methylene links of L are independently replaced with -O- or -NR-; TBM is a target binding moiety, wherein the target binding moiety is a BRD4 binding moiety, wherein the BRD4 binding moiety is
; m is 0, 1, 2, 3 or 4; and each R is independently hydrogen. Invention also relates to a pharmaceutical composition containing said compound, and to a method of destroying a target protein in a biological sample using the same, wherein the target protein is BRD4.
EFFECT: substances providing degradation of proteins and their application are disclosed.
6 cl, 4 tbl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
OXOALKYILIDENE COMPLEXES OF TUNGSTEN FOR Z-SELECTIVE OLEFINES METHATHESIS | 2012 |
|
RU2634708C9 |
HETEROARYL COMPOUNDS AND USING THEM | 2009 |
|
RU2536584C2 |
AZAINDOLES, USEFUL AS INHIBITORS OF JAK AND OTHER PROTEINKINASES | 2005 |
|
RU2403252C2 |
PI3-KINASE INHIBITORS AND USE THEREOF | 2010 |
|
RU2595718C2 |
COMPOUNDS APPLICABLE FOR NEURODEGENERATIVE DISORDERS | 2006 |
|
RU2461562C2 |
INHIBITORS OF PROTEASE OF HEPATITIS C VIRUS AND THEIR APPLICATION | 2008 |
|
RU2515318C2 |
GCN2 INHIBITORS AND THEIR USE | 2019 |
|
RU2811403C2 |
INHIBITORS OF PROTEASE OF HEPATITIS C VIRUS AND THEIR APPLICATION | 2008 |
|
RU2523790C2 |
COMPOUND AIMED AT PROTEIN AND DEGRADATION THEREOF, AND METHOD FOR PRODUCTION AND USE THEREOF | 2021 |
|
RU2829459C1 |
PROSTATIC SPECIFIC MEMBRANE ANTIGEN-TARGETED HIGH-AFFINITY AGENTS FOR PROSTATE CANCER ENDORADIOTHERAPY | 2017 |
|
RU2749399C2 |
Authors
Dates
2024-11-18—Published
2018-09-21—Filed